Information for "Basic safety regarding pentavalent DTaPIPVHib blend vaccine throughout postmarketing surveillance within Guangzhou China through 2011 to be able to 2017"

From EECH Central
Jump to: navigation, search

Basic information

Display titleBasic safety regarding pentavalent DTaPIPVHib blend vaccine throughout postmarketing surveillance within Guangzhou China through 2011 to be able to 2017
Default sort keyBasic safety regarding pentavalent DTaPIPVHib blend vaccine throughout postmarketing surveillance within Guangzhou China through 2011 to be able to 2017
Page length (in bytes)3,837
Page ID1369412
Page content languageEnglish (en)
Page content modelwikitext
Indexing by robotsAllowed
Number of redirects to this page0

Page protection

EditAllow all users (infinite)
MoveAllow all users (infinite)

Edit history

Page creatorRadiowax10 (Talk | contribs)
Date of page creation10:52, 15 April 2024
Latest editorRadiowax10 (Talk | contribs)
Date of latest edit10:52, 15 April 2024
Total number of edits1
Total number of distinct authors1
Recent number of edits (within past 90 days)1
Recent number of distinct authors1